Skip to main content
Top of the Page
+61 08 8334 1900
Become a member
What do we stand for
Benefits & discounts
Categories & Fees
Refer a member
Professional & Industrial Support
Staffing Issues Reporting Tool
Terms and conditions
Year of the Health and Care Worker
Save SA Services
Stand Up - Enterprise Bargaining
Stop the violence in healthcare
Aged Care: It's not too much to ask
Action for health
Health Policy Position Statement
2021 Annual Professional Conference
CPD face to face
Student loans & funding
FAQ - COVID Vaccinations
Aged Care Information
FAQ - Public Sector Workers
FAQ - Aged Care and Private Sector Workers
FAQ - Safety and PPE
Moderna (Spikevax) Covid-19 vaccination
11 August 2021
On 9 August 2021, the Therapeutic Goods Administration (TGA) gave provisional approval for the Moderna vaccine, whose brand name is Spikevax to be used within Australia.
This is the fourth vaccine to be given approval and the second mRNA vaccine approved.
The Moderna vaccine, like all provisionally approved vaccines, has undergone robust scientific evaluation to determine their safety, efficacy and quality and their safety is closely and continually monitored after approval.
The Moderna vaccine has been approved for people 18 years and older and will be given in 2 doses 28 days apart.
Access to this vaccine is expected in September 2021 as the Australian Government has secured 25 million doses, with 10 million being delivered in 2021 and the remaining 15 million doses delivered in 2022.
Further information regarding the Covid-19 vaccinations, how they work, their safety and the contraindications and precautionary advice for Pfizer and Astra Zeneca vaccines can be found here -
Australian Nursing & Midwifery Federation
1. Statement for healthcare professionals: How COVID-19 vaccines are regulated for safety and effectiveness (Revised 11 June 2021) | International Coalition of Medicines Regulatory Authorities (ICMRA)
2. TGA provisionally approves Moderna’s COVID-19 vaccine | Therapeutic Goods Administration (TGA)
An engaging three-day event you won't want to miss.
Back to Top